Liabilities / Assets
59th percentile
Higher debt load relative to assets than 59% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.37x
Liabilities / Revenue
38th percentile
Higher debt load relative to revenue than 38% of similar nonprofits.
Net Margin
34th percentile
Higher net margin than 34% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
27th percentile
Faster asset growth than 27% of similar nonprofits.
Revenue Growth
65th percentile
Faster revenue growth than 65% of similar nonprofits.
Balance Sheet
Assets
Up$152,171,181
Up $705,929 (+0.5%) from 2022
Net Assets
Up$96,370,383
Up $602,814 (+0.6%) from 2022
Liabilities
Up$55,800,798
Up $103,115 (+0.2%) from 2022
Revenue And Expenses
Revenue
Up$172,749,079
Up $15,089,213 (+9.6%) from 2022
Expenses
Up$173,901,699
Up $8,950,144 (+5.4%) from 2022
Net Income
Up-$1,152,620
Up $6,139,069 (+84%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
Inspired by the gift of donation from our communities, allosource responsibly provides innovative cellular and tissue allografts to advance patient healing.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $152,171,181
- Liabilities
- $55,800,798
- Net assets
- $96,370,383
- Revenue
- $172,749,079
- Expenses
- $173,901,699
- Net income
- -$1,152,620